About Xelect
Xelect is a company based in United Kingdom founded in 2013 by Tom Ashton and Ian Alistair Johnston. Xelect has raised $240.84 thousand across 3 funding rounds from investors including European Union and EOS Technology Investment Syndicate. Xelect offers products and services including Breeding Programme Management, Genetics Laboratory Services, and Due Diligence Services. Xelect operates in a competitive market with competitors including Hendrix Genetics, AnimalBiome, Basepaws, Embark Veterinary and AquaBounty, among others.
- Headquarter United Kingdom
- Founders Tom Ashton, Ian Alistair Johnston
-
Sectors
HealthcareAgriculture
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Xelect Limited
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$240.84 K (USD)
in 3 rounds
-
Latest Funding Round
$97.17 K (USD), Grant
May 01, 2019
-
Investors
European Union
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Xelect
Xelect offers a comprehensive portfolio of products and services, including Breeding Programme Management, Genetics Laboratory Services, and Due Diligence Services.
Manages selective breeding for improved aquaculture species growth.
Provides genetic testing and analysis for aquaculture applications.
Offers technical analysis for aquaculture sector risks and opportunities.
Funding Insights of Xelect
Xelect has successfully raised a total of $240.84K across 3 strategic funding rounds. The most recent funding activity was a Grant round of $97.17 thousand completed in May 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Xelect
Xelect has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and EOS Technology Investment Syndicate.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Xelect
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Xelect
Investment portfolio details for Xelect
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Xelect
Detailed financials for Xelect
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Xelect Comparisons
Peer comparison for Xelect
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Xelect
Xelect operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Hendrix Genetics, AnimalBiome, Basepaws, Embark Veterinary and AquaBounty, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Hybrid animal varieties are developed through marker-assisted breeding methods.
|
|
| Locked | Locked | Locked |
Animal microbiome diagnostics services for pet care are offered.
|
|
| Locked | Locked | Locked |
Provider of genetic testing for cats
|
|
| Locked | Locked | Locked |
Proivder of DNA test kits for dogs that enable dog owners to provide better pet care
|
|
| Locked | Locked | Locked |
Hybrid salmon, trout, and tilapia are produced in aquaculture operations.
|
|
| Locked | Locked | Locked |
Genetic breeding services for aquaculture species are provided.
|
Detailed competitors of Xelect
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Xelect
Complete news archive for Xelect
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Xelect
Xelect was founded in 2013.
Xelect is headquartered in United Kingdom.
Ian Alistair Johnston is the current CEO of Xelect. They have also founded this company.
Xelect is a funded company, having raised a total of $240.84K across 3 funding rounds to date.
Xelect was established in 2013 in the United Kingdom as a company focused on the aquaculture sector. Genetic technologies are applied to breed enhanced seafood strains, supporting sustainable production. Operations involve selective breeding programs and research into traits like disease resistance and growth rates. The company is led by co-founders Tom Ashton and Ian Alistair Johnston, the latter serving as CEO. Services are targeted at seafood producers seeking improved genetics.
Xelect's top competitors include Embark Veterinary, AquaBounty and Benchmark Genetics.
Xelect offers Breeding Programme Management, Genetics Laboratory Services, and Due Diligence Services.
Xelect has 2 investors. Key investors include European Union, and EOS Technology Investment Syndicate.